The mechanism of viral 2B protein to assist EV-A71 to evade the type I IFN-mediated broad-spectrum antiviral effects through promoting KPNA1 degradation, probably via its N-terminal H1 domain, is one of many strategies used by EV-A71 during its infection. Here, KPNA1 is linked to infection.